Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin.

M. H. Robertson, Jon Hanifin, Frank Parker

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Oral ketoconazole therapy was evaluated with 21 patients who had recalcitrant dermatophytosis. During an 18-week period, all patients, including three with organisms resistant to griseofulvin in vitro, showed impressive clinical improvement. The four patients without nail involvement became mycologically negative earlier than those with onychomycosis. The latter group showed progressive clearing of the nails, but only three were mycologically clear after 18 weeks. Adverse reactions to ketoconazole were negligible, and no patients required discontinuance of the drug. Ketoconazole appears to be a safe, effective drug for oral therapy of dermatophytoses in humans.

Original languageEnglish (US)
Pages (from-to)578-581
Number of pages4
JournalReviews of Infectious Diseases
Volume2
Issue number4
StatePublished - Jul 1980
Externally publishedYes

Fingerprint

Griseofulvin
Arthrodermataceae
Ketoconazole
Tinea
Nails
Infection
Onychomycosis
Therapeutics
Drug Therapy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin. / Robertson, M. H.; Hanifin, Jon; Parker, Frank.

In: Reviews of Infectious Diseases, Vol. 2, No. 4, 07.1980, p. 578-581.

Research output: Contribution to journalArticle

@article{fe39e293c7bf4640b08c175712c441c6,
title = "Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin.",
abstract = "Oral ketoconazole therapy was evaluated with 21 patients who had recalcitrant dermatophytosis. During an 18-week period, all patients, including three with organisms resistant to griseofulvin in vitro, showed impressive clinical improvement. The four patients without nail involvement became mycologically negative earlier than those with onychomycosis. The latter group showed progressive clearing of the nails, but only three were mycologically clear after 18 weeks. Adverse reactions to ketoconazole were negligible, and no patients required discontinuance of the drug. Ketoconazole appears to be a safe, effective drug for oral therapy of dermatophytoses in humans.",
author = "Robertson, {M. H.} and Jon Hanifin and Frank Parker",
year = "1980",
month = "7",
language = "English (US)",
volume = "2",
pages = "578--581",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Oral therapy with ketoconazole for dermatophyte infections unresponsive to griseofulvin.

AU - Robertson, M. H.

AU - Hanifin, Jon

AU - Parker, Frank

PY - 1980/7

Y1 - 1980/7

N2 - Oral ketoconazole therapy was evaluated with 21 patients who had recalcitrant dermatophytosis. During an 18-week period, all patients, including three with organisms resistant to griseofulvin in vitro, showed impressive clinical improvement. The four patients without nail involvement became mycologically negative earlier than those with onychomycosis. The latter group showed progressive clearing of the nails, but only three were mycologically clear after 18 weeks. Adverse reactions to ketoconazole were negligible, and no patients required discontinuance of the drug. Ketoconazole appears to be a safe, effective drug for oral therapy of dermatophytoses in humans.

AB - Oral ketoconazole therapy was evaluated with 21 patients who had recalcitrant dermatophytosis. During an 18-week period, all patients, including three with organisms resistant to griseofulvin in vitro, showed impressive clinical improvement. The four patients without nail involvement became mycologically negative earlier than those with onychomycosis. The latter group showed progressive clearing of the nails, but only three were mycologically clear after 18 weeks. Adverse reactions to ketoconazole were negligible, and no patients required discontinuance of the drug. Ketoconazole appears to be a safe, effective drug for oral therapy of dermatophytoses in humans.

UR - http://www.scopus.com/inward/record.url?scp=0019043422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019043422&partnerID=8YFLogxK

M3 - Article

C2 - 6255533

AN - SCOPUS:0019043422

VL - 2

SP - 578

EP - 581

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 4

ER -